Samsrita Labs Ltd
Samsrita Labs | 539267
- Share Price Chart
Stock Performance
Ratios
About Company
- Samsrita Labs Limited was initially established as 'Dr Habeebullah Life Sciences Limited' on January 25, 1996
- The name of the Company was changed from Dr Habeebullah Life Sciences Limited to Samsrita Labs Limited on October 13, 2022
- Company, initially focused on three different verticals called, Stem cell related Hospitals, Molecular Diagnostics and R&D in New Drug Discovery but due to other reasons, aimed to shifting into Bio-pharma activities like Trading, Exports & Imports, manufacturing of Bulk drugs, APIs, Specialty drugs, R&D etc through joint ventures or associations or mergers or by its own
- The Company is engaged into the business of research & experimental development on natural sciences and engineering, including bio pharma and hospital services also
- In 2017, the Company changed its Main Objects clauses by venturing into the business of Bio-Pharma and also entered the following areas like New Drug Discovery including New Molecular Entity (NME - Pro Drug); Clinical Research Organization (CRO) related activities; Stem Cell - Lab, Research and Therapy; Research and Development in Bio-technology; Consultancy Division and Pharmacy; Academic Services like Courses / Lectures / Seminars on Biotechnology, Pharma, Stem Cell Research and therapy, Clinical Research and animal studies etc
- ; Nutraceuticals product development; Trading, exporting and importing of medicinal drugs, chemicals, re-agents etc
- In 2016-17, the Company entered into a Collaborative Agreement with Krisani Bio Sciences Private Limited for further development of NASH (Fatty Liver) Molecule and Wilson Disease Molecule on revenue sharing basis and also entered into a Collaborative Agreement with Centre For liver Research And Diagnostics (CLRD) to use their land , building, equipment and other facilities to run their business of Hospital, Diagnostics, Pharmacy, Stem cell and other bio-technology laboratories on revenue sharing basis
- A diversified healthcare company with innovation is at the forefront of research and development in stem cells & regenerative medicine, new drug discovery, RNAi therapeutics, biomarker discovery
- The Company was named after late Dr
- CM Habeebullah, whose dedication and passion form the backbone of the Company's core values to provide affordable, world class cutting edge healthcare facilities to all
Research Calls
Technical Indicators
Pivot Points
No Information Available
Volume Analysis data is not available at this time.
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Group Stocks
Frequently Asked Questions
What is Share Price of Samsrita Labs Ltd?
The current share price of Samsrita Labs Ltd (Samsrita Labs) is ₹11.72. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Samsrita Labs Ltd?
The Price-to-Earnings (P/E) ratio of Samsrita Labs Ltd is 11.72. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Samsrita Labs Ltd?
Samsrita Labs Ltd has a 52-week high of ₹25.27 and a 52-week low of ₹10.15. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Samsrita Labs Ltd?
Samsrita Labs Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Samsrita Labs Ltd?
The Earnings Per Share (EPS) of Samsrita Labs Ltd is ₹-3.59. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Samsrita Labs Ltd?
Samsrita Labs Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
